SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-304916
Filing Date
2022-12-14
Accepted
2022-12-14 17:20:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d432196ds3.htm S-3 235299
2 EX-5.1 d432196dex51.htm EX-5.1 7080
3 EX-23.2 d432196dex232.htm EX-23.2 1636
4 EX-FILING FEES d432196dexfilingfees.htm EX-FILING FEES 21519
5 GRAPHIC g432196g03a31.jpg GRAPHIC 40783
6 GRAPHIC g432196g1213120114501.jpg GRAPHIC 2414
  Complete submission text file 0001193125-22-304916.txt   322501
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268798 | Film No.: 221462973
SIC: 2836 Biological Products, (No Diagnostic Substances)